We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWTX icon
501
Edgewise Therapeutics
EWTX
$4.28B
$2.66M 0.02%
298,000
+108,000
+57% +$1.01M
ATO icon
502
Atmos Energy
ATO
$29.7B
$2.65M 0.02%
23,665
-7,117
-23% -$783K
ROST icon
503
Ross Stores
ROST
$80.8B
$2.64M 0.02%
22,757
-2,070
-8% -$211K
SDGR icon
504
Schrodinger
SDGR
$1.13B
$2.62M 0.02%
+140,000
New +$2.9M
TTD icon
505
Trade Desk
TTD
$8.97B
$2.6M 0.02%
58,033
+37,985
+189% +$1.93M
LEVI icon
506
Levi Strauss
LEVI
$9.49B
$2.6M 0.02%
167,543
– –
RJF icon
507
Raymond James Financial
RJF
$33.5B
$2.58M 0.02%
24,152
-875
-3% -$98.2K
ZNTL icon
508
Zentalis Pharmaceuticals
ZNTL
$332M
$2.58M 0.02%
127,973
– –
ORLY icon
509
O'Reilly Automotive
ORLY
$75.1B
$2.57M 0.02%
45,720
-4,710
-9% -$253K
INFY icon
510
Infosys
INFY
$51B
$2.56M 0.02%
142,414
-20,838
-13% -$388K
BX icon
511
Blackstone
BX
$104B
$2.55M 0.02%
34,419
+14
+0% +$1.21K
OMC icon
512
Omnicom Group
OMC
$23.5B
$2.54M 0.02%
31,177
-11,660
-27% -$866K
SNOW icon
513
Snowflake
SNOW
$98.1B
$2.5M 0.02%
17,432
+1,511
+9% +$231K
TROW icon
514
T. Rowe Price
TROW
$25.5B
$2.48M 0.02%
22,710
+4,185
+23% +$473K
SJR
515
DELISTED
Shaw Communications Inc.
SJR
$2.46M 0.02%
85,591
-20,987
-20% -$551K
CBOE icon
516
Cboe Global Markets
CBOE
$32.2B
$2.46M 0.02%
19,622
+1,660
+9% +$205K
CEG icon
517
Constellation Energy
CEG
$92.1B
$2.45M 0.02%
28,436
-1,248
-4% -$112K
LEN icon
518
Lennar Class A
LEN
$20.4B
$2.45M 0.02%
27,951
-5,391
-16% -$437K
HUBB icon
519
Hubbell
HUBB
$24.4B
$2.44M 0.02%
+10,393
New +$2.49M
FAST icon
520
Fastenal
FAST
$54.8B
$2.43M 0.02%
102,772
-3,520
-3% -$86.1K
TMCI icon
521
Treace Medical Concepts
TMCI
$262M
$2.41M 0.02%
105,000
– –
PPG icon
522
PPG Industries
PPG
$24.9B
$2.37M 0.02%
18,840
+387
+2% +$47.4K
LPX icon
523
Louisiana-Pacific
LPX
$5.14B
$2.37M 0.02%
40,000
-22,235
-36% -$1.31M
SNA icon
524
Snap-on
SNA
$21.5B
$2.35M 0.02%
10,297
+611
+6% +$138K
O icon
525
Realty Income
O
$61.1B
$2.35M 0.02%
37,064
-1,507
-4% -$93.6K
19 20
21
22 23

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.